NCT02365766 Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT02365207 Intravesical BCG Administration to Patients With Invasive Bladder Cancer Status TERMINATED Phase NA
NCT02346955 Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) Status TERMINATED Phase PHASE1
NCT02345473 Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy Status COMPLETED Phase N/A
NCT02340650 High Resolution Imaging for Early and Better Detection of Bladder Cancer Status COMPLETED Phase N/A
NCT02326168 PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02307487 Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients Status COMPLETED Phase PHASE2
NCT02302807 A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] Status COMPLETED Phase PHASE3
NCT02300610 Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer Status COMPLETED Phase PHASE1
NCT02298998 Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study Status COMPLETED Phase N/A
NCT02287701 Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization Status COMPLETED Phase NA
NCT02281383 Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer Status COMPLETED Phase PHASE2
NCT02233842 Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors Status COMPLETED Phase N/A